FDA Person
FDAJonathan W. Chapman
View detailed information about Jonathan W. Chapman, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Jonathan W. Chapman, including their role, qualifications, and regulatory activities.
Recent Records (18)
483 - Wuxi Biologics Co Ltd
483
EIR - Wuxi Biologics Co Ltd
EIR
EIR - Supernus Pharmaceuticals, Inc.
EIR
483 - Wuxi Biologics Co Ltd
483
483 - Shanghai Desano Bio-Pharmaceutical Co., Ltd.
483
EIR - Wuxi Biologics Co Ltd
EIR
483 - Pharmaceutics International Inc
483
483 - Barr Laboratories Inc.
483
483 - Zhejiang Huahai Pharmaceutical Co., Ltd.
483
483 - Shandong Anhong Pharmaceutical Co., Ltd.
483
483 - Bora Pharmaceuticals Injectables Inc
483
483 - Hainan Shuangcheng Pharmaceuticals Co Ltd
483
483 - Johns Hopkins University PET Center
483
483 - Pharmaceutics International, Inc.
483
483 - Yino, Inc. (Trading Company)
483
483 - Zhejiang Huahai Pharmaceutical Co., Ltd.
483
483 - Taizhou Kangping Medical Science And Technology Co., Ltd.
483
483 - Supernus Pharmaceuticals, Inc.
483
Person Information
Name
Jonathan W. Chapman
Title
investigator
Role
COMPANY REP
ID: 5b5134c3-71f9-4212-9429-4554d91e8aa9
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.